Drug intelligence / Profile preview

CXLO Corneal Strengthening Solution

Development stage
Unknown
Lead developer
Glaukos
Modality
Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Topical, Ophthalmic
01

Overview

CXLO Corneal Strengthening Solution is a sterile ophthalmic solution intended for use in corneal cross-linking (CXL) procedures, primarily for the treatment of progressive keratoconus and secondary corneal ectasia. It contains riboflavin (vitamin B2, typically as riboflavin 5'-phosphate or sodium riboflavin phosphate) as the active ingredient, combined with hydroxypropyl methylcellulose (HPMC) in a buffered isotonic solution. The solution is designed for topical application during CXL procedures, where riboflavin acts as a photoenhancer, absorbing UVA (365 nm) light to generate reactive oxygen species (primarily superoxide anion). These reactive species induce additional covalent cross-links between collagen fibers, resulting in biomechanical stiffening of the corneal stroma, thus halting or slowing ectatic disease progression. The inclusion of HPMC, instead of dextran, helps avoid intraoperative stromal dehydration and maintains corneal thickness and transparency during the procedure. CXLO Corneal Strengthening Solution is distinguished by optimized osmolarity and higher riboflavin concentration, designed for rapid and homogenous stromal penetration[1].

Brand names
CXLO Corneal Strengthening Solution
Other names
CXLO Corneal Strengthening Solution

Beyond the preview

Go deeper on CXLO Corneal Strengthening Solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CXLO Corneal Strengthening Solution.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call